BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12115380)

  • 1. Facing a prostate cancer diagnosis: who is at risk for increased distress?
    Perczek RE; Burke MA; Carver CS; Krongrad A; Terris MK
    Cancer; 2002 Jun; 94(11):2923-9. PubMed ID: 12115380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
    Ulloa EW; Salup R; Patterson SG; Jacobsen PB
    Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating peer support for prostate cancer: the Prostate Cancer Peer Support Inventory.
    Steginga SK; Pinnock C; Gardner M; Gardiner RA; Dunn J
    BJU Int; 2005 Jan; 95(1):46-50. PubMed ID: 15663527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological distress in Japanese men with localized prostate cancer.
    Namiki S; Saito S; Tochigi T; Numata I; Ioritani N; Arai Y
    Int J Urol; 2007 Oct; 14(10):924-9. PubMed ID: 17880290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of dispositional emotional expressivity and social constraints on distress among prostate cancer patients in Iceland.
    Agustsdottir S; Kristinsdottir A; Jonsdottir K; Larusdottir SO; Smari J; Valdimarsdottir HB
    Br J Health Psychol; 2010 Feb; 15(Pt 1):51-61. PubMed ID: 19341530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
    van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW
    J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological distress and prostate specific antigen levels in men with and without prostate cancer.
    Turner EL; Lane JA; Metcalfe C; Down L; Donovan JL; Hamdy F; Neal D; Vedhara K
    Brain Behav Immun; 2009 Nov; 23(8):1073-8. PubMed ID: 19486654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. After prostate cancer: predictors of well-being among long-term prostate cancer survivors.
    Blank TO; Bellizzi KM
    Cancer; 2006 May; 106(10):2128-35. PubMed ID: 16607648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The measurement of psychological distress in men being investigated for the presence of prostate cancer.
    Awsare NS; Green JS; Aldwinckle B; Hanbury DC; Boustead GB; McNicholas TA
    Prostate Cancer Prostatic Dis; 2008; 11(4):384-9. PubMed ID: 18427569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Describing and predicting psychological distress after colorectal cancer.
    Lynch BM; Steginga SK; Hawkes AL; Pakenham KI; Dunn J
    Cancer; 2008 Mar; 112(6):1363-70. PubMed ID: 18318044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of wives to prostate cancer following diagnosis and 3 months after treatment: a test of family adaptation theory.
    Ezer H; Ricard N; Bouchard L; Souhami L; Saad F; Aprikian A; Taguchi Y
    Int J Nurs Stud; 2006 Sep; 43(7):827-38. PubMed ID: 16876802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
    Davison BJ; Goldenberg SL; Gleave ME; Degner LF
    Oncol Nurs Forum; 2003; 30(1):107-14. PubMed ID: 12515988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
    Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
    BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of affect following treatment decision-making for prostate cancer: conversations, cognitive processing, and coping.
    Christie KM; Meyerowitz BE; Giedzinska-Simons A; Gross M; Agus DB
    Psychooncology; 2009 May; 18(5):508-14. PubMed ID: 18756584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coping strategies and psychological distress in patients with advanced cancer.
    Zabalegui A
    Oncol Nurs Forum; 1999 Oct; 26(9):1511-8. PubMed ID: 11064882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in health-related quality of life of prostate cancer patients based on stage of cancer.
    Rosenfeld B; Roth AJ; Gandhi S; Penson D
    Psychooncology; 2004 Nov; 13(11):800-7. PubMed ID: 15386638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.